Global Diagnostic Imaging (CT, MRI, X-Ray & Ultrasound) Market - Competitive Landscape & Forecasts from 2010 to 2016
Report Description:
The global diagnostic imaging market is expected to grow from $20.7 billion in 2010 to $26.6 billion by 2016, at an estimated CAGR of 4.2% from 2011 to 2016. Increasing aging population and widening applications of diagnostic imaging due to continuous developments are predominantly driving the diagnostic imaging market. In addition, with increasing awareness amongst consumers regarding preventive care and development of products that result in harmless imaging is further receiving a boost.
The emerging trend that is catching interest of the players is fusion of nuclear imaging with different modalities of diagnostic imaging products. The merging of imaging modalities such as PET/CT, SPECT/CT, and MRI/PET help in providing full gamut of imaging scans through the same unit and at the same time. Further, portable diagnostic equipments are also facing an immense demand from physicians.
X-ray constituted the largest percentage share of around 34% share in 2010; followed by Ultrasound (21%), CT scan (19.5%), MRI (18.5%), and nuclear
medicine (7%). With respect to geographies, the market is dominated by America with a total market share of around 36.3% in 2010, followed by Europe (27.3%), Asia (27%), and ROW (9.4%).
GE (U.S.), Philips (The Netherlands), and Siemens (Germany) together constitute the majority of the market with Philips market share equaled to GE due to increased focus towards the emerging market. The other players that are rapidly gaining presence in the market are Toshiba (Japan), Hitachi (Japan), and Hologic (U.S.).
Scope of the report
This research report evaluates the global diagnostic imaging market with respect to the product market. The report analyzes geography; forecasting revenues, and trends in each of the following submarkets:
What makes our reports unique?
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
The global diagnostic imaging market is expected to grow from $20.7 billion in 2010 to $26.6 billion by 2016, at an estimated CAGR of 4.2% from 2011 to 2016. Increasing aging population and widening applications of diagnostic imaging due to continuous developments are predominantly driving the diagnostic imaging market. In addition, with increasing awareness amongst consumers regarding preventive care and development of products that result in harmless imaging is further receiving a boost.
The emerging trend that is catching interest of the players is fusion of nuclear imaging with different modalities of diagnostic imaging products. The merging of imaging modalities such as PET/CT, SPECT/CT, and MRI/PET help in providing full gamut of imaging scans through the same unit and at the same time. Further, portable diagnostic equipments are also facing an immense demand from physicians.
X-ray constituted the largest percentage share of around 34% share in 2010; followed by Ultrasound (21%), CT scan (19.5%), MRI (18.5%), and nuclear
medicine (7%). With respect to geographies, the market is dominated by America with a total market share of around 36.3% in 2010, followed by Europe (27.3%), Asia (27%), and ROW (9.4%).
GE (U.S.), Philips (The Netherlands), and Siemens (Germany) together constitute the majority of the market with Philips market share equaled to GE due to increased focus towards the emerging market. The other players that are rapidly gaining presence in the market are Toshiba (Japan), Hitachi (Japan), and Hologic (U.S.).
Scope of the report
This research report evaluates the global diagnostic imaging market with respect to the product market. The report analyzes geography; forecasting revenues, and trends in each of the following submarkets:
- X-ray
- CT
- MRI
- Ultrasound
- Nuclear imaging
What makes our reports unique?
- We provide the longest market segmentation chain in this industry.
- We provide 10% customization. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
- Which are the high-growth segments/cash cows and how is the market segmented in terms of the diagnostic imaging market?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
2 MARKET OVERVIEW
2.1 INTRODUCTION
2.2 DIAGNOSTIC IMAGING MARKET
2.3 BURNING ISSUES
2.3.1 INCREASE IN AGING POPULATION DRIVING DEMAND
2.3.2 WIDER APPLICATIONS OF IMAGING MODALITIES
2.3.3 INCREASED USE & ACCEPTANCE OF IMAGING
2.3.4 HEALTHCARE SPENDING & REIMBURSEMENT ISSUE
2.3.5 INCREASING CONSUMER AWARENESS FOR PREVENTIVE DIAGNOSTIC SCREENING
2.4 TRENDS & DEVELOPMENTS
2.4.1 FUSION & MULTIMODALITY
2.4.2 PORTABLE IMAGING EQUIPMENT
2.4.3 LOW COST DIAGNOSTIC EQUIPMENT TAKES PRECEDENCE OVER TRADITIONAL EQUIPMENT
2.4.4 INCREASING PARTNERSHIP WITH OEMS
2.4.5 ESTABLISHING VENTURE FOR TECHNOLOGY
2.4.6 COST OPTIMIZATION THROUGH SOFTWARE
2.5 MARKET DYNAMICS & IMPACT ANALYSIS
2.6 WINNING IMPERATIVES
2.6.1 FOCUSING ON EMERGING MARKETS
2.6.2 COST REDUCTION THROUGH TECHNOLOGY SOLUTIONS
2.6.3 TECHNOLOGY ADVANCEMENT & INNOVATIONS
3 MARKET – BY PRODUCTS
3.1 INTRODUCTION
3.2 X-RAY
3.2.1 OVERVIEW
3.2.1.1 General X-ray
3.2.1.2 Cardiovascular X-ray
3.2.2 TRENDS & DEVELOPMENTS
3.2.3 PRICING & ANALYSIS
3.2.4 DRIVERS
3.2.4.1 Low cost & portable X-ray
3.2.4.2 Digital mammography
3.3 COMPUTED TOMOGRAPHY (CT)
3.3.1 OVERVIEW
3.3.1.1 Low slice
3.3.1.2 Mid slice
3.3.1.3 High slice
3.3.2 TRENDS & DEVELOPMENTS
3.3.3 PRICING & ANALYSIS
3.3.4 TECHNOLOGY INNOVATION (HIGH SLICE) DRIVES THE MARKET
3.3.5 RADIATION DOSE IS A CONCERN
3.4 MAGNETIC RESONANCE IMAGING
3.4.1 OVERVIEW
3.4.1.1 Closed MRI
3.4.1.2 Open MRI
3.4.1.3 Low field MRI
3.4.1.4 Mid field MRI
3.4.1.5 High field MRI
3.4.2 TRENDS & DEVELOPMENTS
3.4.3 PRICING & ANALYSIS
3.4.4 DRIVERS
3.4.4.1 Increasing use of MRI in other clinical applications
3.4.4.2 Latest technology upgradation
3.4.4.3 Increasing number of breast MRIs
3.5 ULTRASOUND
3.5.1 OVERVIEW
3.5.2 TRENDS & DEVELOPMENTS
3.5.3 PRICING & ANALYSIS
3.5.4 PORTABLE ULTRASOUND DRIVES THE MARKET
3.6 NUCLEAR IMAGING
3.6.1 OVERVIEW
3.6.2 TRENDS & DEVELOPMENTS
3.6.3 PRICING & ANALYSIS
3.6.4 FUSION WITH OTHER MODALITIES DRIVES THE MARKET
3.7 OTHER IMAGING MODALITIES
3.7.1 OVERVIEW
3.7.1.1 Power injection systems
3.7.2 TRENDS & DEVELOPMENTS
4 GEOGRAPHICAL ANALYSIS
4.1 INTRODUCTION
4.2 AMERICAS
4.2.1 OVERVIEW
4.2.2 REGULATIONS
4.2.3 DRIVERS
4.2.3.1 Increase in aging population
4.2.3.2 Rise in chronic diseases and related cost
4.2.4 RESTRAINTS
4.2.4.1 Radiation exposure
4.2.4.2 Reimbursement
4.3 EUROPE
4.3.1 OVERVIEW
4.3.1.1 Germany
4.3.1.2 France
4.3.1.3 Italy
4.3.1.4 Spain
4.3.1.5 UK
4.3.2 DRIVERS
4.3.2.1 Aging population
4.3.2.2 Rise of chronic disease population
4.3.3 RESTRAINTS
4.3.3.1 Decrease in healthcare expenditure
4.3.3.2 Stringent regulations
4.3.4 REGULATIONS
4.4 ASIA-PACIFIC
4.4.1 OVERVIEW
4.4.1.1 China
4.4.1.2 India
4.4.1.3 Japan
4.4.2 DRIVERS, RESTRAINTS & OPPORTUNITIES
4.4.2.1 China
4.4.2.1.1 Healthcare reforms
4.4.2.1.2 Increase in aging population will drive demand for medical imaging devices
4.4.2.1.3 Replacement of old medical devices
4.4.2.1.4 Uncertain regulatory policies and delays in registration
4.4.2.2 India
4.4.2.2.1 Technology & innovation
4.4.2.2.2 Increasing demand for quality healthcare
4.4.2.2.3 India’s rising medical tourism
4.4.2.2.4 Increasing investment in government & private sector
4.4.2.2.5 Ease of regulations
4.4.2.3 Japan
4.4.2.3.1 Aging population
4.4.2.3.2 Advancement in technology
4.4.2.3.3 Healthcare spending & reimbursement
4.4.2.3.4 Increasing number of people suffering from chronic diseases
4.4.3 REGULATIONS
4.4.3.1 China
4.4.3.2 India
4.4.3.3 Japan
4.5 ROW
4.5.1 OVERVIEW
4.5.1.1 Egypt
4.5.1.2 Israel
4.5.1.3 Morocco
4.5.1.4 South Africa
4.5.2 DRIVERS, RESTRAINTS & OPPORTUNITIES
4.5.2.1 Egypt
4.5.2.1.1 Health care reform
4.5.2.1.2 Red Tapism
4.5.2.1.3 Non-transparency
4.5.2.2 Israel
4.5.2.2.1 Over burdened hospitals require advanced facilities
4.5.2.2.2 Growing medical tourism
4.5.2.2.3 Government investment in healthcare
4.5.2.3 Morocco
4.5.2.3.1 Increasing population & need of advanced healthcare system
4.5.2.3.2 Increasing government spending in healthcare
4.5.2.4 South Africa
4.5.2.4.1 Incoming plans to develop new hospitals
4.5.2.4.2 Increasing chronic disease population
4.5.3 REGULATIONS
4.5.3.1 Egypt
4.5.3.2 Israel
4.5.3.3 Morocco
4.5.3.4 South Africa
5 COMPETITIVE LANDSCAPE
5.1 INTRODUCTION
5.2 MAGNETIC RESONANCE IMAGING (MRI)
5.3 X-RAY
5.4 COMPUTED TOMOGRAPHY(CT)
5.5 ULTRASOUND
5.6 NUCLEAR IMAGING
6 COMPANY PROFILES
6.1 AGFA-GEVAERT N.V. (AGFA)
6.1.1 OVERVIEW
6.1.2 FINANCIALS
6.1.3 PRODUCTS & SERVICES
6.1.4 STRATEGY
6.1.5 DEVELOPMENTS
6.2 ALOKA INC
6.2.1 OVERVIEW
6.2.2 FINANCIALS
6.2.3 PRODUCTS & SERVICES
6.2.4 STRATEGY
6.2.5 DEVELOPMENTS
6.3 BRACCO IMAGING S.P.A.
6.3.1 OVERVIEW
6.3.2 FINANCIALS
6.3.3 PRODUCTS & SERVICES
6.3.4 STRATEGY
6.3.5 DEVELOPMENTS
6.4 CARESTREAM HEALTH
6.4.1 OVERVIEW
6.4.2 FINANCIALS
6.4.3 PRODUCTS & SERVICES
6.4.4 STRATEGY
6.4.5 DEVELOPMENTS
6.5 ESOATE S.P.A.
6.5.1 OVERVIEW
6.5.2 FINANCIALS
6.5.3 PRODUCTS & SERVICES
6.5.4 STRATEGY
6.5.5 DEVELOPMENTS
6.6 FUJIFILM HOLDINGS CORP
6.6.1 OVERVIEW
6.6.2 FINANCIALS
6.6.3 PRODUCTS & SERVICES
6.6.4 STRATEGY
6.6.5 DEVELOPMENTS
6.7 GE HEALTHCARE
6.7.1 OVERVIEW
6.7.2 FINANCIALS
6.7.3 PRODUCTS & SERVICES
6.7.4 STRATEGY
6.7.5 DEVELOPMENTS
6.8 HITACHI LTD
6.8.1 OVERVIEW
6.8.2 FINANCIALS
6.8.3 PRODUCTS & SERVICES
6.8.4 STRATEGY
6.8.5 DEVELOPMENTS
6.9 HOLOGIC INC
6.9.1 OVERVIEW
6.9.2 PRODUCT & SERVICES
6.9.3 FINANCIALS
6.9.4 STRATEGY
6.9.5 DEVELOPMENTS
6.1 MEDRAD INC
6.10.1 OVERVIEW
6.10.2 FINANCIALS
6.10.3 PRODUCTS & SERVICES
6.10.4 STRATEGY
6.10.5 DEVELOPMENTS
6.11 MINDRAY MEDICAL INTERNATIONAL LTD (MINDRAY)
6.11.1 OVERVIEW
6.11.2 FINANCIALS
6.11.3 PRODUCTS & SERVICES
6.11.4 STRATEGY
6.11.5 DEVELOPMENTS
6.12 PHILIPS HEALTHCARE
6.12.1 OVERVIEW
6.12.2 FINANCIALS
6.12.3 PRODUCTS & SERVICES
6.12.4 STRATEGY
6.12.5 DEVELOPMENTS
6.13 SHIMADZU CORP
6.13.1 OVERVIEW
6.13.2 FINANCIALS
6.13.3 PRODUCTS & SERVICES
6.13.4 STRATEGY
6.13.5 DEVELOPMENTS
6.14 SIEMENS HEALTHCARE
6.14.1 OVERVIEW
6.14.2 FINANCIALS
6.14.3 PRODUCTS & SERVICES
6.14.4 STRATEGY
6.14.5 DEVELOPMENTS
6.15 SONOSITE INC
6.15.1 OVERVIEW
6.15.2 FINANCIALS
6.15.3 PRODUCTS & SERVICES
6.15.4 STRATEGY
6.15.5 DEVELOPMENTS
6.16 TOSHIBA AMERICA MEDICAL SYSTEMS INC
6.16.1 OVERVIEW
6.16.2 FINANCIALS
6.16.3 PRODUCTS & SERVICES
6.16.4 STRATEGY
6.16.5 DEVELOPMENTS
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
2 MARKET OVERVIEW
2.1 INTRODUCTION
2.2 DIAGNOSTIC IMAGING MARKET
2.3 BURNING ISSUES
2.3.1 INCREASE IN AGING POPULATION DRIVING DEMAND
2.3.2 WIDER APPLICATIONS OF IMAGING MODALITIES
2.3.3 INCREASED USE & ACCEPTANCE OF IMAGING
2.3.4 HEALTHCARE SPENDING & REIMBURSEMENT ISSUE
2.3.5 INCREASING CONSUMER AWARENESS FOR PREVENTIVE DIAGNOSTIC SCREENING
2.4 TRENDS & DEVELOPMENTS
2.4.1 FUSION & MULTIMODALITY
2.4.2 PORTABLE IMAGING EQUIPMENT
2.4.3 LOW COST DIAGNOSTIC EQUIPMENT TAKES PRECEDENCE OVER TRADITIONAL EQUIPMENT
2.4.4 INCREASING PARTNERSHIP WITH OEMS
2.4.5 ESTABLISHING VENTURE FOR TECHNOLOGY
2.4.6 COST OPTIMIZATION THROUGH SOFTWARE
2.5 MARKET DYNAMICS & IMPACT ANALYSIS
2.6 WINNING IMPERATIVES
2.6.1 FOCUSING ON EMERGING MARKETS
2.6.2 COST REDUCTION THROUGH TECHNOLOGY SOLUTIONS
2.6.3 TECHNOLOGY ADVANCEMENT & INNOVATIONS
3 MARKET – BY PRODUCTS
3.1 INTRODUCTION
3.2 X-RAY
3.2.1 OVERVIEW
3.2.1.1 General X-ray
3.2.1.2 Cardiovascular X-ray
3.2.2 TRENDS & DEVELOPMENTS
3.2.3 PRICING & ANALYSIS
3.2.4 DRIVERS
3.2.4.1 Low cost & portable X-ray
3.2.4.2 Digital mammography
3.3 COMPUTED TOMOGRAPHY (CT)
3.3.1 OVERVIEW
3.3.1.1 Low slice
3.3.1.2 Mid slice
3.3.1.3 High slice
3.3.2 TRENDS & DEVELOPMENTS
3.3.3 PRICING & ANALYSIS
3.3.4 TECHNOLOGY INNOVATION (HIGH SLICE) DRIVES THE MARKET
3.3.5 RADIATION DOSE IS A CONCERN
3.4 MAGNETIC RESONANCE IMAGING
3.4.1 OVERVIEW
3.4.1.1 Closed MRI
3.4.1.2 Open MRI
3.4.1.3 Low field MRI
3.4.1.4 Mid field MRI
3.4.1.5 High field MRI
3.4.2 TRENDS & DEVELOPMENTS
3.4.3 PRICING & ANALYSIS
3.4.4 DRIVERS
3.4.4.1 Increasing use of MRI in other clinical applications
3.4.4.2 Latest technology upgradation
3.4.4.3 Increasing number of breast MRIs
3.5 ULTRASOUND
3.5.1 OVERVIEW
3.5.2 TRENDS & DEVELOPMENTS
3.5.3 PRICING & ANALYSIS
3.5.4 PORTABLE ULTRASOUND DRIVES THE MARKET
3.6 NUCLEAR IMAGING
3.6.1 OVERVIEW
3.6.2 TRENDS & DEVELOPMENTS
3.6.3 PRICING & ANALYSIS
3.6.4 FUSION WITH OTHER MODALITIES DRIVES THE MARKET
3.7 OTHER IMAGING MODALITIES
3.7.1 OVERVIEW
3.7.1.1 Power injection systems
3.7.2 TRENDS & DEVELOPMENTS
4 GEOGRAPHICAL ANALYSIS
4.1 INTRODUCTION
4.2 AMERICAS
4.2.1 OVERVIEW
4.2.2 REGULATIONS
4.2.3 DRIVERS
4.2.3.1 Increase in aging population
4.2.3.2 Rise in chronic diseases and related cost
4.2.4 RESTRAINTS
4.2.4.1 Radiation exposure
4.2.4.2 Reimbursement
4.3 EUROPE
4.3.1 OVERVIEW
4.3.1.1 Germany
4.3.1.2 France
4.3.1.3 Italy
4.3.1.4 Spain
4.3.1.5 UK
4.3.2 DRIVERS
4.3.2.1 Aging population
4.3.2.2 Rise of chronic disease population
4.3.3 RESTRAINTS
4.3.3.1 Decrease in healthcare expenditure
4.3.3.2 Stringent regulations
4.3.4 REGULATIONS
4.4 ASIA-PACIFIC
4.4.1 OVERVIEW
4.4.1.1 China
4.4.1.2 India
4.4.1.3 Japan
4.4.2 DRIVERS, RESTRAINTS & OPPORTUNITIES
4.4.2.1 China
4.4.2.1.1 Healthcare reforms
4.4.2.1.2 Increase in aging population will drive demand for medical imaging devices
4.4.2.1.3 Replacement of old medical devices
4.4.2.1.4 Uncertain regulatory policies and delays in registration
4.4.2.2 India
4.4.2.2.1 Technology & innovation
4.4.2.2.2 Increasing demand for quality healthcare
4.4.2.2.3 India’s rising medical tourism
4.4.2.2.4 Increasing investment in government & private sector
4.4.2.2.5 Ease of regulations
4.4.2.3 Japan
4.4.2.3.1 Aging population
4.4.2.3.2 Advancement in technology
4.4.2.3.3 Healthcare spending & reimbursement
4.4.2.3.4 Increasing number of people suffering from chronic diseases
4.4.3 REGULATIONS
4.4.3.1 China
4.4.3.2 India
4.4.3.3 Japan
4.5 ROW
4.5.1 OVERVIEW
4.5.1.1 Egypt
4.5.1.2 Israel
4.5.1.3 Morocco
4.5.1.4 South Africa
4.5.2 DRIVERS, RESTRAINTS & OPPORTUNITIES
4.5.2.1 Egypt
4.5.2.1.1 Health care reform
4.5.2.1.2 Red Tapism
4.5.2.1.3 Non-transparency
4.5.2.2 Israel
4.5.2.2.1 Over burdened hospitals require advanced facilities
4.5.2.2.2 Growing medical tourism
4.5.2.2.3 Government investment in healthcare
4.5.2.3 Morocco
4.5.2.3.1 Increasing population & need of advanced healthcare system
4.5.2.3.2 Increasing government spending in healthcare
4.5.2.4 South Africa
4.5.2.4.1 Incoming plans to develop new hospitals
4.5.2.4.2 Increasing chronic disease population
4.5.3 REGULATIONS
4.5.3.1 Egypt
4.5.3.2 Israel
4.5.3.3 Morocco
4.5.3.4 South Africa
5 COMPETITIVE LANDSCAPE
5.1 INTRODUCTION
5.2 MAGNETIC RESONANCE IMAGING (MRI)
5.3 X-RAY
5.4 COMPUTED TOMOGRAPHY(CT)
5.5 ULTRASOUND
5.6 NUCLEAR IMAGING
6 COMPANY PROFILES
6.1 AGFA-GEVAERT N.V. (AGFA)
6.1.1 OVERVIEW
6.1.2 FINANCIALS
6.1.3 PRODUCTS & SERVICES
6.1.4 STRATEGY
6.1.5 DEVELOPMENTS
6.2 ALOKA INC
6.2.1 OVERVIEW
6.2.2 FINANCIALS
6.2.3 PRODUCTS & SERVICES
6.2.4 STRATEGY
6.2.5 DEVELOPMENTS
6.3 BRACCO IMAGING S.P.A.
6.3.1 OVERVIEW
6.3.2 FINANCIALS
6.3.3 PRODUCTS & SERVICES
6.3.4 STRATEGY
6.3.5 DEVELOPMENTS
6.4 CARESTREAM HEALTH
6.4.1 OVERVIEW
6.4.2 FINANCIALS
6.4.3 PRODUCTS & SERVICES
6.4.4 STRATEGY
6.4.5 DEVELOPMENTS
6.5 ESOATE S.P.A.
6.5.1 OVERVIEW
6.5.2 FINANCIALS
6.5.3 PRODUCTS & SERVICES
6.5.4 STRATEGY
6.5.5 DEVELOPMENTS
6.6 FUJIFILM HOLDINGS CORP
6.6.1 OVERVIEW
6.6.2 FINANCIALS
6.6.3 PRODUCTS & SERVICES
6.6.4 STRATEGY
6.6.5 DEVELOPMENTS
6.7 GE HEALTHCARE
6.7.1 OVERVIEW
6.7.2 FINANCIALS
6.7.3 PRODUCTS & SERVICES
6.7.4 STRATEGY
6.7.5 DEVELOPMENTS
6.8 HITACHI LTD
6.8.1 OVERVIEW
6.8.2 FINANCIALS
6.8.3 PRODUCTS & SERVICES
6.8.4 STRATEGY
6.8.5 DEVELOPMENTS
6.9 HOLOGIC INC
6.9.1 OVERVIEW
6.9.2 PRODUCT & SERVICES
6.9.3 FINANCIALS
6.9.4 STRATEGY
6.9.5 DEVELOPMENTS
6.1 MEDRAD INC
6.10.1 OVERVIEW
6.10.2 FINANCIALS
6.10.3 PRODUCTS & SERVICES
6.10.4 STRATEGY
6.10.5 DEVELOPMENTS
6.11 MINDRAY MEDICAL INTERNATIONAL LTD (MINDRAY)
6.11.1 OVERVIEW
6.11.2 FINANCIALS
6.11.3 PRODUCTS & SERVICES
6.11.4 STRATEGY
6.11.5 DEVELOPMENTS
6.12 PHILIPS HEALTHCARE
6.12.1 OVERVIEW
6.12.2 FINANCIALS
6.12.3 PRODUCTS & SERVICES
6.12.4 STRATEGY
6.12.5 DEVELOPMENTS
6.13 SHIMADZU CORP
6.13.1 OVERVIEW
6.13.2 FINANCIALS
6.13.3 PRODUCTS & SERVICES
6.13.4 STRATEGY
6.13.5 DEVELOPMENTS
6.14 SIEMENS HEALTHCARE
6.14.1 OVERVIEW
6.14.2 FINANCIALS
6.14.3 PRODUCTS & SERVICES
6.14.4 STRATEGY
6.14.5 DEVELOPMENTS
6.15 SONOSITE INC
6.15.1 OVERVIEW
6.15.2 FINANCIALS
6.15.3 PRODUCTS & SERVICES
6.15.4 STRATEGY
6.15.5 DEVELOPMENTS
6.16 TOSHIBA AMERICA MEDICAL SYSTEMS INC
6.16.1 OVERVIEW
6.16.2 FINANCIALS
6.16.3 PRODUCTS & SERVICES
6.16.4 STRATEGY
6.16.5 DEVELOPMENTS
LIST OF TABLES
TABLE 1 DIAGNOSTIC IMAGING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 2 X-RAY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 3 GENERAL X-RAY: TRENDS & DEVELOPMENTS
TABLE 4 CARDIOVASCULAR X-RAY: TRENDS & DEVELOPMENTS
TABLE 5 COMPUTED TOMOGRAPHY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 6 COMPUTED TOMOGRAPHY MARKET REVENUE, BY TYPES, 2009 – 2016 ($BILLION)
TABLE 7 CT: TRENDS & DEVELOPMENTS
TABLE 8 MRI MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 9 MRI MARKET REVENUE, BY TYPES, 2009 – 2016 ($BILLION)
TABLE 10 MRI MARKET REVENUE, BY FIELD TYPES, 2009 – 2016 ($BILLION)
TABLE 11 MRI: TRENDS & DEVELOPMENTS
TABLE 12 ULTRASOUND MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 13 ULTRASOUND: TRENDS & DEVELOPMENTS
TABLE 14 NUCLEAR IMAGING MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 15 NUCLEAR MEDICINE: TRENDS & DEVELOPMENTS
TABLE 16 POWER INJECTABLES: TRENDS & DEVELOPMENTS
TABLE 17 DIAGNOSTIC MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 18 AMERICAS: DIAGNOSTIC MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 19 AMERICAS: CT UNITS INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION POPULATION)
TABLE 20 AMERICAS: MRI INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION POPULATION)
TABLE 21 EUROPE: DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 22 EUROPE: CT UNITS INSTALLATION,BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 23 EUROPE: MRI UNITS INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 24 WESTERN DIAGNOSTIC IMAGING MARKET, BY COUNTRIES, 2009 – 2016 ($BILLION)
TABLE 25 ASIA-PACIFIC: DIAGNOSTIC IMAGING MARKET REVENUE,
BY COUNTRIES, 2009 – 2016 ($BILLION)
TABLE 26 ASIA-PACIFIC: CT UNITS INSTALLATION, BY COUNTRIES,
2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 27 ASIA-PACIFIC: MRI UNITS INSTALLATION, BY COUNTRIES,
2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 28 CHINA: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 29 INDIA: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 30 JAPAN: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 31 ROW: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 32 TOTAL MARKET REVENUE AND R&D EXPENSES FOR FISCAL YEAR ENDED MARCH 31 ($BILLION)
TABLE 33 AGFA: MARKET REVENUE, BY GEOGRAPHY, 2010 ($BILLION)
TABLE 34 AGFA: MARKET REVENUE BREAK UP, BY SEGMENTS, 2010 ($BILLION)
TABLE 35 FUJIFILM: TOTAL MARKET REVENUE AND R&D EXPENSES FOR FISCAL YEAR ENDED MARCH 31 ($BILLION)
TABLE 36 FUJIFILM: MARKET REVENUE SPILT, BY GEOGRAPHY, 2010 ($BILLION)
TABLE 37 FUJIFILM: TOTAL MARKET REVENUE SPLIT, BY SEGMENTS, 2010 ($BILLION)
TABLE 38 GE HEALTHCARE: TOTAL REVENUE& R&D EXPENSES, 2008 - 2010 ($BILLION)
TABLE 39 GE HEALTHCARE: SALES, BY GEOGRAPHY, 2008 - 2010 ($BILLION)
TABLE 40 GE HEALTHCARE: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 41 GE HEALTHCARE: MARKET REVENUE, BY TECHNOLOGY INFRASTRUCTURE SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 42 HITACHI MEDICAL CORP: TOTAL SALES AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 43 HITACHI MEDICAL CORP: TOTAL SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 44 HITACHI MEDICAL CORP: TOTAL SALES, BY SEGMENT, 2007 - 2009 ($MILLION)
TABLE 45 HOLOGIC: MARKET REVENUE, 2008 - 2010 ($MILLION)
TABLE 46 HOLOGIC: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 47 HOLOGIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 48 MINDRAY: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($BILLION)
TABLE 49 MINDRAY: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($BILLION)
TABLE 50 MINDRAY: MARKET REVENUE, BY SEGMENT, 2008 – 2010 ($MILLION)
TABLE 51 PHILIPS HEALTHCARE: REVENUE & R&D EXPENSES, 2008 - 2010 ($BILLION)
TABLE 52 PHILIPS HEALTHCARE: SALES, BY GEOGRAPHY, 2008 - 2010 ($BILLION)
TABLE 53 SHIMADZU: MARKET REVENUE, 2008 – 2010 ($MILLION)
TABLE 54 SHIMADZU: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 55 SHIMADZU: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 56 SIEMENS: REVENUE & R&D EXPENCES ($MILLION)
TABLE 57 SIEMENS: REVENUE, BY SEGMENTS ($MILLION)
TABLE 58 SIEMENS: REVENUE, BY SEGMENTS ($MILLION)
TABLE 59 SONOSITE INC: TOTAL REVENUE & R&D EXPENSES ($MILLION)
TABLE 60 SONOSITE INC: REVENUE, BY GEOGRAPHY ($MILLION)
TABLE 1 DIAGNOSTIC IMAGING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 2 X-RAY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 3 GENERAL X-RAY: TRENDS & DEVELOPMENTS
TABLE 4 CARDIOVASCULAR X-RAY: TRENDS & DEVELOPMENTS
TABLE 5 COMPUTED TOMOGRAPHY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 6 COMPUTED TOMOGRAPHY MARKET REVENUE, BY TYPES, 2009 – 2016 ($BILLION)
TABLE 7 CT: TRENDS & DEVELOPMENTS
TABLE 8 MRI MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 9 MRI MARKET REVENUE, BY TYPES, 2009 – 2016 ($BILLION)
TABLE 10 MRI MARKET REVENUE, BY FIELD TYPES, 2009 – 2016 ($BILLION)
TABLE 11 MRI: TRENDS & DEVELOPMENTS
TABLE 12 ULTRASOUND MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 13 ULTRASOUND: TRENDS & DEVELOPMENTS
TABLE 14 NUCLEAR IMAGING MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 15 NUCLEAR MEDICINE: TRENDS & DEVELOPMENTS
TABLE 16 POWER INJECTABLES: TRENDS & DEVELOPMENTS
TABLE 17 DIAGNOSTIC MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 18 AMERICAS: DIAGNOSTIC MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($BILLION)
TABLE 19 AMERICAS: CT UNITS INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION POPULATION)
TABLE 20 AMERICAS: MRI INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION POPULATION)
TABLE 21 EUROPE: DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY, 2009 - 2016 ($BILLION)
TABLE 22 EUROPE: CT UNITS INSTALLATION,BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 23 EUROPE: MRI UNITS INSTALLATION, BY COUNTRIES, 2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 24 WESTERN DIAGNOSTIC IMAGING MARKET, BY COUNTRIES, 2009 – 2016 ($BILLION)
TABLE 25 ASIA-PACIFIC: DIAGNOSTIC IMAGING MARKET REVENUE,
BY COUNTRIES, 2009 – 2016 ($BILLION)
TABLE 26 ASIA-PACIFIC: CT UNITS INSTALLATION, BY COUNTRIES,
2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 27 ASIA-PACIFIC: MRI UNITS INSTALLATION, BY COUNTRIES,
2007 – 2009 (UNITS PER MILLION OF POPULATION)
TABLE 28 CHINA: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 29 INDIA: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 30 JAPAN: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 31 ROW: DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCTS,
2009 – 2016 ($BILLION)
TABLE 32 TOTAL MARKET REVENUE AND R&D EXPENSES FOR FISCAL YEAR ENDED MARCH 31 ($BILLION)
TABLE 33 AGFA: MARKET REVENUE, BY GEOGRAPHY, 2010 ($BILLION)
TABLE 34 AGFA: MARKET REVENUE BREAK UP, BY SEGMENTS, 2010 ($BILLION)
TABLE 35 FUJIFILM: TOTAL MARKET REVENUE AND R&D EXPENSES FOR FISCAL YEAR ENDED MARCH 31 ($BILLION)
TABLE 36 FUJIFILM: MARKET REVENUE SPILT, BY GEOGRAPHY, 2010 ($BILLION)
TABLE 37 FUJIFILM: TOTAL MARKET REVENUE SPLIT, BY SEGMENTS, 2010 ($BILLION)
TABLE 38 GE HEALTHCARE: TOTAL REVENUE& R&D EXPENSES, 2008 - 2010 ($BILLION)
TABLE 39 GE HEALTHCARE: SALES, BY GEOGRAPHY, 2008 - 2010 ($BILLION)
TABLE 40 GE HEALTHCARE: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 41 GE HEALTHCARE: MARKET REVENUE, BY TECHNOLOGY INFRASTRUCTURE SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 42 HITACHI MEDICAL CORP: TOTAL SALES AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 43 HITACHI MEDICAL CORP: TOTAL SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 44 HITACHI MEDICAL CORP: TOTAL SALES, BY SEGMENT, 2007 - 2009 ($MILLION)
TABLE 45 HOLOGIC: MARKET REVENUE, 2008 - 2010 ($MILLION)
TABLE 46 HOLOGIC: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 47 HOLOGIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 48 MINDRAY: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($BILLION)
TABLE 49 MINDRAY: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($BILLION)
TABLE 50 MINDRAY: MARKET REVENUE, BY SEGMENT, 2008 – 2010 ($MILLION)
TABLE 51 PHILIPS HEALTHCARE: REVENUE & R&D EXPENSES, 2008 - 2010 ($BILLION)
TABLE 52 PHILIPS HEALTHCARE: SALES, BY GEOGRAPHY, 2008 - 2010 ($BILLION)
TABLE 53 SHIMADZU: MARKET REVENUE, 2008 – 2010 ($MILLION)
TABLE 54 SHIMADZU: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 55 SHIMADZU: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 56 SIEMENS: REVENUE & R&D EXPENCES ($MILLION)
TABLE 57 SIEMENS: REVENUE, BY SEGMENTS ($MILLION)
TABLE 58 SIEMENS: REVENUE, BY SEGMENTS ($MILLION)
TABLE 59 SONOSITE INC: TOTAL REVENUE & R&D EXPENSES ($MILLION)
TABLE 60 SONOSITE INC: REVENUE, BY GEOGRAPHY ($MILLION)
LIST OF FIGURES
FIGURE 1 MEDICAL DEVICE MARKET, BY GEOGRAPHY, 2010
FIGURE 2 MEDICAL DEVICE MARKET, BY TYPES
FIGURE 3 MEDICAL IMAGING MARKET, BY GEOGRAPHY
FIGURE 4 IMPACT ANALYSIS ON IMAGING MARKET
FIGURE 5 BREAKUP OF IMAGING MARKET MODALITIES
FIGURE 6 BREAKUP OF X-RAY MARKET IN PERCENTAGE, 2010
FIGURE 7 DIAGNOSTIC MARKET SHARE, BY GEOGRAPHY, 2010
FIGURE 8 AMERICAS: DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY, 2010
FIGURE 9 U.S: POPULATION TRENDS, 1950 – 2030 (MILLION)
FIGURE 10 CHRONIC DISEASE POPULATION (BILLION) & RELATED COST (MILLION), 1995 – 2030
FIGURE 11 GLOBAL DIAGNOSTIC IMAGING MARKET SHARE, 2010
FIGURE 12 GLOBAL MRI MARKET SHARE, 2010
FIGURE 13 GLOBAL COMPUTED TOMOGRAPHY MARKET SHARE, 2010
FIGURE 14 GLOBAL ULTRASOUND MARKET, 2010
FIGURE 15 GLOBAL NUCLEAR IMAGING MARKET SHARE, 2010
FIGURE 1 MEDICAL DEVICE MARKET, BY GEOGRAPHY, 2010
FIGURE 2 MEDICAL DEVICE MARKET, BY TYPES
FIGURE 3 MEDICAL IMAGING MARKET, BY GEOGRAPHY
FIGURE 4 IMPACT ANALYSIS ON IMAGING MARKET
FIGURE 5 BREAKUP OF IMAGING MARKET MODALITIES
FIGURE 6 BREAKUP OF X-RAY MARKET IN PERCENTAGE, 2010
FIGURE 7 DIAGNOSTIC MARKET SHARE, BY GEOGRAPHY, 2010
FIGURE 8 AMERICAS: DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY, 2010
FIGURE 9 U.S: POPULATION TRENDS, 1950 – 2030 (MILLION)
FIGURE 10 CHRONIC DISEASE POPULATION (BILLION) & RELATED COST (MILLION), 1995 – 2030
FIGURE 11 GLOBAL DIAGNOSTIC IMAGING MARKET SHARE, 2010
FIGURE 12 GLOBAL MRI MARKET SHARE, 2010
FIGURE 13 GLOBAL COMPUTED TOMOGRAPHY MARKET SHARE, 2010
FIGURE 14 GLOBAL ULTRASOUND MARKET, 2010
FIGURE 15 GLOBAL NUCLEAR IMAGING MARKET SHARE, 2010
